Human TNF-alpha cDNA
Alternative name | Human TNF alpha cDNA |
---|---|
Clone info. | Human TNF alpha cDNA |
Vector backbone | pBluescript II SK (+) (Plasmid) |
Size of vector backbone | 3.0 kb |
Selectable markers | Amp^r |
Gene/insert name | Human TNF-alpha cDNA |
Depositor|Developer | Hamada, Hirofumi | |
Additional map | ![]() |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB01477 | pBluescript SKII+hTNF alpha | DNA solution | Please contact us. |
Materials & Methods section:
The pBluescript SKII+hTNF alpha was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01477). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB14264_A6Gjp1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 Sequence file: RDB14264_A6Gja.seq ![]() |
---|
>01477_14264_A6Gj_M13(-40)_A01_01.ab1 1 CCGGCCTGTG CGCGCGTATA CGACTCACTA TAGGGCGAAT TGGGTACCGG GCCCCCCCTC 61 GAGGTCGACG GTATCGATAA GCTTGATATC GAATTCTAGA CACCATGAGC ACTGAAAGCA 121 TGATCCGGGA CGTGGAGCTG GCCGAGGAGG CGCTCCCCAA GAAGACAGGG GGGCCCCAGG 181 GCTCCAGGCG GTGCTTGTTC CTCAGCCTCT TCTCCTTCCT GATCGTGGCA GGCGCCACCA 241 CGCTCTTCTG CCTGCTGCAC TTTGGAGTGA TCGGCCCCCA GAGGGAAGAG TTCCCCAGGG 301 ACCTCTCTCT AATCAGCCCT CTGGCCCAGG CAGTCAGATC ATCTTCTCGA ACCCCGAGTG 361 ACAAGCCTGT AGCCCATGTT GTAGCAAACC CTCAAGCTGA GGGGCAGCTC CAGTGGCTGA 421 ACCGCCGGGC CAATGCCCTC CTGGCCAATG GCGTGGAGCT GAGAGATAAC CAGCTGGTGG 481 TGCCATCAGA GGGCCTGTAC CTCATCTACT CCCAGGTCCT CTTCAAGGGC CAAGGCTGCC 541 CCTCCACCCA TGTGCTCCTC ACCCACACCA TCAGCCGCAT CGCCGTCTCC TACCAGACCA 601 AGGTCAACCT CCTCTCTGCC ATCAAGAGCC CCTGCCAGAG GGAGACCCCA GAGGGGGCTG 661 AGGCCAAGCC CTGGTATGAG CCCATCTATC TGGGAGGGGT CTTCCAGCTG GAGAAGGGTG 721 ACCGACTCAG CGCTGAGATC AATCGGCCCG ACTATCTCGA CTTTGCCGAG TCTGGGCAGG 781 TCTACTTTGG GATCATTGCC CTGTGACTCG AGGATCCACT AGTTCTAGAG CGGCCGCCAC 841 CGCGGTGGAG CTCCAGCTTT TGTTCCCTTT AGTGAGGGTT AATTGCGCGC TTGGCGTAAT 901 CATGGTCATA GCTGTTTCCT GTGTGAAATT GTTTATCCGC TCACAAATTC CACACAACAT 961 ACGAGCCCGG GAAGCATAAA GTGTAAAGCC TGGGGTGCCC TAAATGAGTG AGCTACTCAC 1021 ATTTAACTGC CGATGCGCTC ACTGGCCCGC TTTCCAGTCA GGCAACCTGA TCGTTGCCAG 1081 CTGTGGCCAA TA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
user_report | Yokoyama, C., Interleukin-8 enhances the effect of colchicine on cell death. Biochem. Biophys. Res. Commun. 485 (1): 89-94 (2017). PMID 28189686. [link to RRC of NBRP] |
---|
Featured content